miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma

Oncology Letters - Greece
doi 10.3892/ol.2020.11452
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Global Hypomethylation Is an Independent Prognostic Factor in Diffuse Large B Cell Lymphoma

American Journal of Hematology
Hematology
2017English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Primary Cutaneous Diffuse Large B-Cell Lymphoma – A Case Report

Serbian Journal of Dermatology and Venereology
Dermatology
2017English

Molecular Analysis of a CD19-negative Diffuse Large B-Cell Lymphoma

Haematologica
Hematology
2018English

Primary Diffuse Large B-Cell Lymphoma of the Mandible

Autopsy and Case Reports
2019English

Epiphyseal Primary Diffuse Large B-Cell Lymphoma of Bone

Case Reports in Pathology
2018English

Diffuse Large B-Cell Lymphoma

2020English

Primary Diffuse Large B-Cell Lymphoma of the Bladder

Internal Medicine
Internal MedicineMedicine
2009English

The Derived Neutrophil to Lymphocyte Ratio Is an Independent Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy